These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6358896)

  • 41. Is reduced cardiac performance the only mechanism for myocardial infarct size reduction during beta adrenergic blockade?
    Stangeland L; Grong K; Vik-Mo H; Andersen KS; Lekven J
    Cardiovasc Res; 1986 May; 20(5):322-30. PubMed ID: 3756974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of intravenous nitroglycerin therapy on infarct size in patients with acute myocardial infarction.
    Raos V; Jeren-Strujić B; Ljutić D; Horvatin-Godler S; Straus B
    Acta Med Croatica; 1995; 49(1):5-14. PubMed ID: 7633178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of propranolol in threatened myocardial infarction.
    Norris RM; Clarke ED; Sammel NL; Smith WM; Williams B
    Lancet; 1978 Oct; 2(8096):907-9. PubMed ID: 81925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: randomized trial to assess infarct size limitation.
    Pabón Osuna P; García Moreno LM; Arribas Jimenez A; Sala Sánchez-Castillo A; Martín Luengo C; Sánchez Hernández J; Castaño Bazo L; Cascón Bueno M; Diego Dominguez M; Ledesma García C
    Am J Cardiol; 1985 Feb; 55(4):330-4. PubMed ID: 3969867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary prevention of myocardial infarction in the elderly.
    Abrahamsen AM; Gundersen T; Rønnevik P
    Curr Med Res Opin; 1982; 7(Suppl 1):68-78. PubMed ID: 7105797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical methods for evaluating infarct size and its anatomic correlations. Study carried out in 193 cases. III. Comparison of data on the evaluation of the infarct size using the QRS score and a method of maximal creatine kinase determination in the serum].
    Perdigão C; Martins C; Andrade A; Bastos C; Monteiro J; Ribeiro C
    Rev Port Cardiol; 1989 Oct; 8(10):705-8. PubMed ID: 2631818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of cumulated CK release with three vectorcardiographic methods of estimating myocardial infarct size.
    Grøttum P; Kjekshus JK
    J Electrocardiol; 1986 Oct; 19(4):337-45. PubMed ID: 3794573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of sodium nitroprusside on mortality in acute myocardial infarction.
    Durrer JD; Lie KI; van Capelle FJ; Durrer D
    N Engl J Med; 1982 May; 306(19):1121-8. PubMed ID: 7040955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of therapy with methylprednisolone on the size of myocardial infarcts in man.
    Peters RW; Norman A; Parmley WW; Emilson BB; Scheinman MM; Cheitlin M
    Chest; 1978 Apr; 73(4):483-8. PubMed ID: 630965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
    Mahaffey KW; Granger CB; Nicolau JC; Ruzyllo W; Weaver WD; Theroux P; Hochman JS; Filloon TG; Mojcik CF; Todaro TG; Armstrong PW;
    Circulation; 2003 Sep; 108(10):1176-83. PubMed ID: 12925455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propranolol in acute myocardial infarction: the MILIS experience.
    Rude RE; Buja LM; Willerson JT
    Am J Cardiol; 1986 Apr; 57(12):38F-42F. PubMed ID: 2871744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Br Heart J; 1985 Aug; 54(2):134-9. PubMed ID: 3893489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemodynamic effects of intravenous sotalol in acute myocardial infarction.
    Aström M; Edhag O; Nyquist O; Vallin H
    Eur Heart J; 1986 Nov; 7(11):931-6. PubMed ID: 3539617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of metoprolol on chest pain in acute myocardial infarction.
    Herlitz J; Hjalmarson A; Holmberg S; Pennert K; Swedberg K; Vedin A; Waagstein F; Waldenström A; Wedel H; Wilhelmsen L
    Br Heart J; 1984 Apr; 51(4):438-44. PubMed ID: 6367784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reduction of CK and CK-MB enzyme levels as indicators of infarct size by intravenous nitroglycerin (author's transl)].
    Bussmann WD; Passek D; Seidel W; Klepzig H; Kaltenbach M
    Z Kardiol; 1980 Jan; 69(1):18-30. PubMed ID: 6774493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostacyclin infusion in patients with acute myocardial infarction.
    Henriksson P; Edhag O; Wennmalm A
    Br Heart J; 1985 Feb; 53(2):173-9. PubMed ID: 2857087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Timolol-related reduction in mortality and reinfarction in diabetic patients surviving acute myocardial infarction.
    Gundersen T; Kjekshus J
    Horm Metab Res Suppl; 1985; 15():58-60. PubMed ID: 3908282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.
    Kiernan FJ; Kluger J; Regnier JC; Rutkowski M; Fieldman A
    Br Heart J; 1986 Nov; 56(5):428-32. PubMed ID: 3539163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.